| Financial Year |
March 31 2023 |
| Monetary Funds |
3,861,818,438.89 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
48,972,249.20 |
| Accounts Receivable |
187,334,666.21 |
| Advances to Suppliers |
95,204,945.07 |
| Other Receivables |
39,567,897.13 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,139,059,296.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,158,630.79 |
| Other Current Assets |
154,795,340.73 |
| Total Current Assets |
6,954,938,948.55 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,548,549,483.45 |
| Under-construction Projects |
651,170,686.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,937,359.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
69,766,660.78 |
| Other Non-Current Assets |
86,370,523.88 |
| Sub-Total of Non-Current Assets |
2,410,194,714.62 |
| Total Assets |
9,365,133,663.17 |
| Short-Term Loans |
77,765,839.03 |
| Trading Financial liabilities |
-- |
| Notes Payable |
146,658,887.17 |
| Accounts Payable |
301,225,200.88 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,993,240.99 |
| Taxes Payable |
99,899,780.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,673,995.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
400,000.00 |
| Other Current Liabilities |
1,964,745.81 |
| Sub-Total of Current Liabilities |
695,894,744.88 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
39,830,200.00 |
| Deferred Income Tax Liabilities |
90,863,646.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
195,281,895.19 |
| Total Liabilities |
891,176,640.07 |
| Paid-In Capital(Or Share Stock) |
226,705,525.00 |
| Capital Surplus |
6,058,334,975.76 |
| Surplus Reserve |
90,658,038.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,007,502,258.20 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,473,957,023.10 |
| Owner's Equity（Stockholder's Equity） |
8,473,957,023.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,365,133,663.17 |
